ACK1/TNK2 tyrosine kinase overexpression role in gastric cancer ACK1/TNK2 tirozin kinaz expresyonun mide kanserindeki rolü


Ercelep O., Keser S., ÖZÇELİK M., Basar M.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.29, sa.2, ss.55-60, 2019 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4999/uhod.192412
  • Dergi Adı: UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.55-60
  • Anahtar Kelimeler: TNK2, ACK1, Gastric cancer, Survival, Overexpression
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

ACK1 or TNK2 integrate signals from ligand active receptor tyrosine kinases, which are exogenous oncogenic nonreceptor tyrosine kinases, to modulate intracellular signaling cascades 1. Several studies have revealed that ACK1/TNK2 is upregulated in various cancers and promotes tumor progression. This study aimed to determine the prognostic role TNK2 overexpression in gastric cancer. Presence of TNK2 overexpression in pathology blocks of patients with non-metastatic operated gastric cancer was used as prognostic marker and survival was investigated. The pathology samples of 129 patients were studied. Mean survival times (64.2 months) of the gastric cancer patients with TNK2 overexpression were significantly longer than those without overexpression (27.1 months) (p= 0.00). Median follow-up was 39 months. TNK2 overexpression rate was 75% in stage 1-2, 56% in stage 3 (p= 0.027). The positive effect of node negativity, ECOG performance status of 0-1 and TNK2 overexpression on survival in gastric cancer was also shown by multivariate analysis. We identified overexpression of the TNK2 in gastric cancer is correlated with good prognosis.